Fig. 2From: The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agentsKaplan–Meier curves of (a) progression-free and (b) overall survival for 215 glioblastoma patients stratified for MSP-positive (blue colour) or MSP-negative (red colour) tumorsBack to article page